Observe Medical ASA: Allocation of offer shares to primary insiders and close associates
Observe Medical ASA (OBSRV) · publisert 2023-12-13 12:43 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Soleglad Invest AS nærstående | Closely associated person of primary insider Kathrine Gamborg Andreassen (board member) | other | 432 692 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 2 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| Ingerø Reiten Investment Company AS nærstående | Closely associated person of primary insider Terje Bakken (chairman of the board) | other | 27 730 757 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 3 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| ELI AS nærstående | Closely associated person of primary insider Eskild Endrerud (board member) | other | 9 269 038 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 4 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| Per Arne Nygård | Chief Financial Officer (CFO) in Observe Medical ASA | other | 450 000 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 5 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| Rune Christian Nystad | Chief Executive Officer (CEO) in Observe Medical ASA | other | 230 769 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 6 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| US Holding AS nærstående | Closely associated person of primary insider Rune Christian Nystad (CEO) | other | 384 615 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 7 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| Line Tønnessen | Member of the board of directors of Observe Medical ASA | other | 432 692 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue / 8 NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE | rules |
| Eskild Endrerud | Member of the board of directors of Observe Medical ASA | other | 637 500 | 0,26 NOK | 2023-12-12 | NO0010865009 | Outside a trading venue | rules |
Vedlegg
- Mandatory_notifications_of_trade.pdf (tekst hentet ut)
Meldingstekst
Reference is made to the stock exchange announcement published by Observe
Medical ASA (the "Company") on 12 December 2023 regarding the final results of
the rights issue (the "Rights Issue").
As of this date, the Company has been informed that certain primary insiders and
close associates have been allocated new shares in the Rights Issue, as set out
in the attached mandatory notifications of trade.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.
For further information about the Company, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.
Further information is available at www.observemedical.com.